中性粒细胞与淋巴细胞比值在脓毒症中的应用进展  

Application of Progress of Neutrophil to Lymphocyte Ratio in Sepsis

作　　者：何缘 王然 郝静 刘怡 王长远[1] 秦俭[1] HE Yuan WANG Ran HAO Jing LIU Yi WANG Changyuan QIN Jian.(Department of Emergency ,Xuanwu Hospital of Capital Medical University ,Beijing 100053, China)

机构地区：[1]首都医科大学宣武医院急诊科,北京100053

出　　处：《医学综述》2017年第18期3595-3598,3603,共5页Medical Recapitulate

基　　金：卫生行业科研专项项目(201002011);首都医科大学本科生创新项目(XSKY2016116)

摘　　要：脓毒症是由感染导致的一种起病急,进展快,预后差的全身炎症反应综合征。近年来,脓毒症的发病率逐年上升,因脓毒症导致的医疗支出和死亡人数也不断增加,已成为危害公共健康的严重问题。因此,早期识别脓毒症及评估脓毒症患者的病情和预后非常重要。中性粒细胞与淋巴细胞比值是一个方便实用的检测指标,可以准确评估脓毒症患者的病情和预后。对于没有能力检测其他昂贵的生物标志物的基层医院来说,中性粒细胞与淋巴细胞比值具有十分重要的临床应用价值。Sepsis is a kind of systemic inflammatory response syndrome with acute onset, fast progression and poor prognosis. In recent years, the incidence of sepsis has been increasing year by year, and the medical expenses and deaths from sepsis are also increasing, which has become a serious problem for public health. Therefore, early identification of sep- sis and the prognosis assessment of patients with sepsis are very important. The ratio of neutrophils to lymphocytes is a con- venient and practical test indicator to accurately assess the disease and prognosis of sepsis patients. Neutrophil to lymphocyte ratio is of great clinical applicative value for primary hospitals without ability to detect other costly biomarkers.

关 键 词：脓毒症 中性粒细胞与淋巴细胞比值 预后 

分 类 号：R631.2[医药卫生—外科学]